Genetic Sequencing

Are you and your partner seeking answers about the cause of your last pregnancy loss and wondering if there is a genetic cause?

We are seeking...

Couples who have experienced 2 or more clinical pregnancy losses AND at least one documented chromosomally normal pregnancy loss for which pregnancy tissue is available

Participants who have chromosomally normal pregnancy loss tissue available will be invited to undergo sequencing. The human genome is large and many changes in our genetic code do not cause disease, but other changes may explain a clinical problem such as miscarriage. Researchers will compare DNA sequences from mothers, fathers, and pregnancy losses to improve our understanding of novel genetic causes of miscarriage. 

Genetic trios composed of a mother, father, and past pregnancies will undergo whole genome sequencing and trio analysis. In some cases, where a genetic cause is suspected based on medical history, sequencing may be offered even if a complete trio is not available.  Living siblings, and additional family members, may provide DNA when available, as this may assist in determining the significance of unknown variants. In addition, couples will be asked to provide a hair sample, optionally, in order to assess for environmental toxins and stress hormones. Enrolled subjects may opt to receive actionable genetic variants that are identified in the trio analysis. Financial compensation is available for couples who are able to provide a complete trio of samples (mother-father-pregnancy loss).

Am I eligible for the Genetic Sequencing Cohort?

You may not be eligible for Genetic Sequencing if...

  • The birthing person has Antiphospholipid Antibody Syndrome
  • You used a donor or gestational carrier
  • You have been diagnosed with congenital uterine anomaly
  • Either parent is a recipient of a bone marrow transplant

 

Can I still participate in the HOPE Registry if I am not eligible for Genetic Sequencing?

Patients enrolled and screened in cohort 1, who are determined to be ineligible for sequencing, due to exclusion criteria or inadequate tissues, will be invited to stay in the registry for clinical observation by use of surveys, and will have the option to provide prospective pregnancy loss tissue should another miscarriage occur.